IFP Advisors
ASND icon

IFP Advisors’s Ascendis Pharma A/S ASND Stock Holding History

IFP Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$152K Buy
667
+236
+55% +$59.8K ﹤0.01% 1711
2026
Q2 		$115K Buy
431
+419
+3,492% +$97.9K ﹤0.01% 1883
2026
Q1 		$2.74K Buy
12
+5
+71% +$1.12K ﹤0.01% 3832
2025
Q4 		$1.49K Buy
7
+1
+17% +$207 ﹤0.01% 3941
2025
Q3 		$1.19K Buy
+6
New +$1.12K ﹤0.01% 3882
2025
Q1 		– Sell
-1
Closed -$138 – 4325
2024
Q4 		$138 Buy
+1
New +$131 ﹤0.01% 3905

Other funds holding ASND

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
ARS Investment Partners
ARS Investment Partners New York $2.23B AUM 74.02% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

IFP Advisors's ASND Position: Q3 2026 in Review

IFP Advisors increased its Ascendis Pharma A/S (ASND) stake by 55% in Q3 2026, buying an estimated $59.8K and bringing the position to 667 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

IFP Advisors first reported a position in ASND in Q4 2024 and has held it in 6 quarters since. 125 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • IFP Advisors held 667 shares of Ascendis Pharma A/S worth $152K as of Q3 2026.
  • IFP Advisors bought 236 Ascendis Pharma A/S shares in Q3 2026, an estimated $59.8K.
  • Ascendis Pharma A/S made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #1711 holding.
  • IFP Advisors first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 6 quarters since.
  • 125 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.